Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experience

Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experience

ABSTRACTAdult patients with newly diagnosed de novo acute myeloid leukemia (AML), who had less than a 50% reduction in blast numbers and with > 15% residual blasts after first cycle of induction chemotherapy, defined as type 1 primary refractory (REF1), have grave prognosis. We retrospectively an...

Full description

Bibliographic Details
Main Authors: Zhiyou Yu, Yao Yao, Yanming Zhang, Jia Chen, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu, Ying Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Hematology
Subjects:
Acute myeloid leukemia
adult
allogeneic stem cell transplantation
primary refractory
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2023.2212534

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2023.2212534

Similar Items